Tan, T. J., Dumbrava, E. E., Frenel, J., Italiano, A., Fagotti, A., Coveler, A. L., Loriot, Y., Luken, M. D. M., Orr, B. C., Ray-Coquard, I. L., Wiesweg, M., Fontana, E., Greystoke, A., Grimison, P. S., LeDuke, K., Schmid, A. N., Jalota, D., Fellous, M. M., Schram, A. M. (2026). Pivotal PYNNACLE phase 2 trial of rezatapopt in heavily pre-treated, advanced solid tumors with a TP53 Y220C mutation: Initial ovarian cancer analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.201